跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AN-PEP
首页
药物
AN-PEP
AN-PEP
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
COMPOSITIONS AND METHODS FOR WOUND HEALING
EP 4422648 A4
申请人: RION INC
优先权: 2021
EP
US
WO
3 件公开
COMPOSITIONS AND METHODS FOR TREATING PULMONARY CONDITIONS
EP 4658279 A1
申请人: MAYO FOUND MEDICAL EDUCATION & RES
优先权: 2023
EP
US
WO
3 件公开
Self-assembling drug amphiphiles and methods for synthesis and use
US 9180203 B2
申请人: UNIV JOHNS HOPKINS
优先权: 2013
US
3 件公开
Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the treatment and a prophylaxis of arteriosclerosis, for the treatment and prevention of allergic reactions of type I according to the gell and coombs classification and for the treatment and prevention of dermatological diseases associated with fo
US 2004132639 A1
申请人: ANSORGE SIEGFRIED
优先权: 2001
CN
US
2 件公开
uPAR selective contrast agent for magnetic resonance imaging
EP 1902734 A1
申请人: DEUTSCHES KREBSFORSCH
优先权: 2006
EP
WO
2 件公开
COMPOSITIONS AND METHODS INVOLVING TRANSFORMING EXTRACELLULAR VESICLES
EP 3826603 A4
申请人: MAYO FOUND MEDICAL EDUCATION & RES
优先权: 2018
EP
US
2 件公开
Method for the diagnosis of neoplastic tissue comprising administering a vasopermeability enhancing peptide of human interleukin-2
US 6737064 B2
申请人: UNIV SOUTHERN CALIFORNIA
优先权: 2002
US
2 件公开
Combinations useful for the treatment of neuronal disorders
US 2005171112 A1
申请人: PROBIODRUG AG
优先权: 2004
US
2 件公开
US 2005137142 A1
申请人: PROBIODRUG AG
优先权: 2004
US
Methods and compositions for modulating C5-a-mediated inflammatory responses
US 2006063701 A1
申请人: OKADA HIDECHIKA
优先权: 2005
US
2 件公开
Microorganisms that co-consume glucose with non-glucose carbohydrates and methods of use
US 10301653 B2
申请人: WISCONSIN ALUMNI RES FOUND
优先权: 2015
US
2 件公开
第 1 / 8 页
上一页
下一页
药物
反馈
